Page 1

Table of Contents ☑ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Delaware Commission file number 001-04321 ANGION BIOMEDICA CORP ( Exact name of registrant as specified in its charter ) ( State or other jurisdiction of incorporation or organization ) 51 Charles Lindbergh Boulevard , Uniondale , New York ( Address of Principal Executive Offices ) 11-3430072 ( I.R.S. Employer Identification No. ) 11553 ( Zip Code ) ( 415 ) 655-4899 Registrant's telephone number , including area code Securities registered pursuant to Section 12 ( b ) of the Act : Title of each class Common Stock , par value $ 0.01 Trading Symbol ( s ) ANGN Name of each exchange on which registered The Nasdaq Global Select Market Securities registered pursuant to section 12 ( g ) of the Act : None . Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes □ No ☑ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes ☑ No □ Indicate by check mark whether the registrant : ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) ; and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes □ No ☑ Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site , if any , every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S- ( §232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit and post such files ) . Yes > No □ Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , or a smaller reporting company . See the definitions of “ large accelerated filer , ” “ accelerated filer , ” “ smaller reporting company " and “ emerging growth company ” in Rule 12b - 2 of the Exchange Act .